Key points from article :
A new artificial pancreas technology is being offered to help manage type 1 diabetes in England.
The artificial pancreas has a sensor placed under the skin and an insulin pump. It automatically monitors blood sugar levels and adjusts the amount of insulin delivered, reducing the need for injections.
The technology has been shown in studies to improve quality of life for people with type 1 diabetes and reduces their risk of serious health problems.
The technology was approved by the National Institute of Health and Care Excellence (Nice) after trials and is now being rolled out by the NHS (National Health Service) in England.
The NHS will begin contacting eligible adults and children with type 1 diabetes to offer them the artificial pancreas. Due to limited availability and training requirements, the full rollout might take up to five years.
This rollout is currently specific to England. Other parts of the UK may offer similar technology in the future.
